Alteration of cell cycle regulators correlates with survival in epithelial ovarian cancer patients

Yasunori Hashiguchi1, Hiroshi Tsuda, Takeshi Inoue

  • 1Department of Obstetrics and Gynecology, Osaka City General Hospital, Japan.

Human Pathology
|March 3, 2004
PubMed

Insights

Alterations in the RB pathway and G2 pathway are linked to poorer survival in epithelial ovarian cancer (EOC) patients. These pathway statuses are independent prognostic factors for EOC, but not related to chemotherapy response.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cell cycle checkpoints, including the G1-S and G2-M phases, are crucial for preventing uncontrolled cell proliferation.
  • Dysregulation of key regulatory pathways like the RB and p53 pathways is implicated in various human cancers, including epithelial ovarian cancer (EOC).
  • Understanding the prognostic significance of these cell cycle pathway alterations in EOC is essential for improving patient outcomes.

Purpose of the Study:

  • To investigate the status of the RB pathway, p53 pathway, and G2 pathway in epithelial ovarian cancer (EOC) patients.
  • To evaluate the association between the status of these cell cycle pathways and patient prognosis, specifically overall survival (OS).
  • To determine if pathway status correlates with response to chemotherapy in EOC.

Main Methods:

  • Immunohistochemistry was employed to analyze the status of the RB, p53, and G2 pathways in 107 epithelial ovarian cancer (EOC) patient samples.
  • Kaplan-Meier analysis and univariate/multivariate analyses were conducted to assess the relationship between pathway status and overall survival.
  • Chemotherapy response data was analyzed in conjunction with pathway status.

Main Results:

  • Altered RB, p53, and G2 pathways were observed in 50.5%, 51.4%, and 33.6% of EOC cases, respectively.
  • Patients with a normal RB pathway exhibited significantly higher overall survival (77.3%) compared to those with an altered RB pathway (50.0%; P = 0.0021).
  • A normal G2 pathway was associated with significantly better OS (66.2%) than an altered G2 pathway (58.3%; P = 0.0416), while p53 pathway status showed no OS correlation. Advanced stage, high histological grade, and altered RB/G2 pathways predicted poor OS.

Conclusions:

  • The status of the RB pathway and the G2 pathway are independent prognostic factors for overall survival in epithelial ovarian cancer (EOC).
  • Altered RB and G2 pathways are significant predictors of poor prognosis in EOC patients.
  • Pathway status did not demonstrate a significant relationship with chemotherapy response in this cohort.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System02:11

The Cell Cycle Control System

The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...